In this study, we compared the post-discharge outcomes of 188 patients discharged from Kameda General Hospital with worsening HF with and without SGLT2 inhibitor treatment, grouped based on BI status at discharge. This evidence concerns the gene SLC5A2 and hydrops fetalis.